{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:12:08Z","timestamp":1753891928036,"version":"3.41.2"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013153","name":"Shantou Science and Technology Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013153","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Recombinant human thrombopoietin (rhTPO) is reported to stimulate platelet production and increase peripheral platelet counts; it is primarily used to manage chemotherapy-induced thrombocytopenia and idiopathic thrombocytopenic purpura. However, the effect of rhTPO in patients with pneumonia and thrombocytopenia remains uncertain.<\/jats:p><jats:p><jats:bold>Objective:<\/jats:bold> To assess the association of rhTPO and platelet counts in ICU patients with pneumonia and thrombocytopenia.<\/jats:p><jats:p><jats:bold>Materials and Methods:<\/jats:bold> A retrospective cohort study was performed in the ICU department, Nanfang Hospital, Southern Medical University, Guangzhou, China. From January 2016 to April 2021, patients with pneumonia and thrombocytopenia were allocated to two groups\u2014the rhTPO and no-rhTPO groups\u2014according to whether they received rhTPO treatment or not during their ICU stay. Demographical and clinical data were collected and analyzed using statistical software; <jats:italic>p<\/jats:italic> &amp;lt; 0.05 was considered statistically significant.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Out of 327 patients, 149 were in the rhTPO group and 178 were in the no-rhTPO group. Within the first 7\u00a0days, platelet counts increased more for patients in the rhTPO group compared with those in the no-rhTPO group (99.21 \u00b1 102.613 vs. 2.08 \u00b1 43.877, <jats:italic>p<\/jats:italic> = 0.000). The clinical recovery rate of platelets increased within 7\u00a0days (65.8 vs. 18.5%, <jats:italic>p<\/jats:italic> = 0.000) and, after 7\u00a0days of enrollment, hemorrhagic scores decreased more apparently in the rhTPO group (2.81 \u00b1 2.856 vs. 1.16 \u00b1 2.123, <jats:italic>p<\/jats:italic> = 0.000). Further, bleeding events ceased in 66.7% of the patients in the rhTPO group compared with 37.3% of the patients in the no-rhTPO group (<jats:italic>p<\/jats:italic> = 0.000). Less red-blood-cells transfusions were needed in the rhTPO group (3.639 \u00b1 4.630 vs. 5.818 \u00b1 6.858, <jats:italic>p<\/jats:italic> = 0.009). Furthermore, through logistic regression, rhTPO administration was found to be an independent indicator that affected the platelet recovery rate within 7\u00a0days.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> This study finds that rhTPO administration is associated with increased platelet counts, alleviated bleeding, and reduced blood transfusion. For patients with pneumonia and thrombocytopenia, rhTPO may be an effective therapeutic drug; however, more RCT trails are needed to confirm our observation.<\/jats:p>","DOI":"10.3389\/fphar.2022.1007719","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T05:41:02Z","timestamp":1665380462000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Administration of recombinant human thrombopoietin is associated with alleviated thrombocytopenia in adult intensive care unit patients with pneumonia: A single-center retrospective study"],"prefix":"10.3389","volume":"13","author":[{"given":"Bailiang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiabin","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nengxian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengli","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaobing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhua","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/00003246-200204000-00005","article-title":"Time course of platelet counts in critically ill patients","volume":"30","author":"Akca","year":"2002","journal-title":"Crit. Care Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/ajh.23275","article-title":"Bleeding and mortality outcomes in ITP clinical trials: A review of thrombopoietin mimetics data","volume":"87","author":"Altomare","year":"2012","journal-title":"Am. J. Hematol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1165\/rcmb.2017-0083OC","article-title":"Platelet depletion impairs host defense to pulmonary infection with Pseudomonas aeruginosa in mice","volume":"58","author":"Amison","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jinf.2007.01.011","article-title":"Impact of thrombocytopenia on outcome of patients admitted to ICU for severe community-acquired pneumonia","volume":"55","author":"Brogly","year":"2007","journal-title":"J. Infect."},{"key":"B5","doi-asserted-by":"publisher","first-page":"S148","DOI":"10.1016\/j.thromres.2018.01.049","article-title":"Platelets, NETs and cancer","volume":"164","author":"Cedervall","year":"2018","journal-title":"Thromb. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1182\/blood-2015-11-680744","article-title":"Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients","volume":"127","author":"Claushuis","year":"2016","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"801","DOI":"10.11915\/j.issn.1671-5403.2019.11.174","article-title":"2019 China guideline for diagnosis and treatment of infection-induced multiple organ dysfunction syndrome in the elderly","volume":"18","year":"2019","journal-title":"Chin. J. Multiple Organ Dis. Elder."},{"key":"B8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.11855\/j.issn.0577-7402.2020.05.01","article-title":"Expert consensus for diagnosis and treatment of thrombocytopenia in adult critical illness in China","volume":"45","year":"2020","journal-title":"Med. J. Chin. People's Liberation Army"},{"key":"B9","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.smim.2016.10.005","article-title":"Platelets and infection","volume":"28","author":"Deppermann","year":"2016","journal-title":"Semin. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1515\/chilat-2016-0007","article-title":"Incidence and predictive value of thrombocytopenia in patients with severe community acquired pneumonia","volume":"15","author":"Dunaiceva","year":"2015","journal-title":"Acta Chir. Latv."},{"key":"B11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/bjh.14423","article-title":"Guidelines for the use of platelet transfusions","volume":"176","author":"Estcourt","year":"2017","journal-title":"Br. J. Haematol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/SHK.0000000000000794","article-title":"Platelet transfusion in critical care and surgery: Evidence-based review of contemporary practice and future directions","volume":"47","author":"Etchill","year":"2017","journal-title":"Shock"},{"key":"B13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1164\/rccm.201501-0140OC","article-title":"Ten-year mortality after community-acquired pneumonia. A prospective cohort","volume":"192","author":"Eurich","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"577303","DOI":"10.3389\/fimmu.2020.577303","article-title":"Platelets and their role in the pathogenesis of cardiovascular events in patients with community-acquired pneumonia","volume":"11","author":"Feldman","year":"2020","journal-title":"Front. Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0140-6736(02)07275-6","article-title":"Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: A randomised, multicentre trial","volume":"359","author":"Godeau","year":"2002","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.3390\/ijms20071730","article-title":"Understanding platelets in infectious and allergic lung diseases","volume":"20","author":"Gomez-Casado","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1080\/09537104.2016.1219032","article-title":"Prognostic significance of platelet count changes during hospitalization for community-acquired pneumonia","volume":"28","author":"Gorelik","year":"2017","journal-title":"Platelets"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.3389\/fimmu.2019.02204","article-title":"The era of thromboinflammation: Platelets are dynamic sensors and effector cells during infectious diseases","volume":"10","author":"Guo","year":"2019","journal-title":"Front. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/107602960200800301","article-title":"Thrombopoietin as a drug: Biologic expectations, clinical realities, and future directions","volume":"8","author":"Haznedaroglu","year":"2002","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"B21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1378\/chest.10-2243","article-title":"The frequency and clinical significance of thrombocytopenia complicating critical illness: A systematic review","volume":"139","author":"Hui","year":"2011","journal-title":"Chest"},{"key":"B22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tracli.2018.06.004","article-title":"Platelet transfusion: Current challenges","volume":"25","author":"Humbrecht","year":"2018","journal-title":"Transfus. Clin. Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3109\/09537104.2015.1010441","article-title":"Platelets in inflammation and infection","volume":"26","author":"Jenne","year":"2015","journal-title":"Platelets"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"861","DOI":"10.4103\/ijccm.IJCCM_279_17","article-title":"Thrombocytopenia in critically ill patients: Clinical and laboratorial behavior and its correlation with short-term outcome during hospitalization","volume":"21","author":"Khurana","year":"2017","journal-title":"Indian J. Crit. care Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"Apache II: A severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit. Care Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1182\/blood-2017-01-761262","article-title":"A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy","volume":"130","author":"Kong","year":"2017","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"S347","DOI":"10.3816\/CLM.2009.s.034","article-title":"New thrombopoietic growth factors","volume":"9","author":"Kuter","year":"2009","journal-title":"Clin. Lymphoma Myeloma"},{"key":"B29","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1152\/physiol.00017.2019","article-title":"Platelet biogenesis in the lung circulation","volume":"34","author":"Lefran\u00e7ais","year":"2019","journal-title":"Physiology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature21706","article-title":"The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors","volume":"544","author":"Lefran\u00e7ais","year":"2017","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/1076029613487429","article-title":"Recombinant human thrombopoietin alleviates infection-associated thrombocytopenia: A retrospective study in senile patients","volume":"21","author":"Lin","year":"2015","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000492187","article-title":"Immune thrombocytopenia - current diagnostics and therapy: Recommendations of a joint working group of DGHO, \u00f6gho, SGH, GPOH, and DGTI","volume":"41","author":"Matzdorff","year":"2018","journal-title":"Oncol. Res. Treat."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and infectious diseases society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1378\/chest.09-0998","article-title":"Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia","volume":"137","author":"Mirsaeidi","year":"2010","journal-title":"Chest"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1097\/00003246-200012000-00017","article-title":"Blunted rise in platelet count in critically ill patients is associated with worse outcome","volume":"28","author":"Nijsten","year":"2000","journal-title":"Crit. Care Med."},{"key":"B36","first-page":"430","article-title":"Is the fall in platelet count associated with intensive care unit acquired pneumonia?","volume":"134","author":"Oguzulgen","year":"2004","journal-title":"Swiss Med. Wkly."},{"key":"B37","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1055\/s-0040-1708827","article-title":"A champion of host defense: A generic large-scale cause for platelet dysfunction and depletion in infection","volume":"46","author":"Page","year":"2020","journal-title":"Semin. Thromb. Hemost."},{"key":"B38","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s00277-017-2953-6","article-title":"Beyond immune thrombocytopenia: The evolving role of thrombopoietin receptor agonists","volume":"96","author":"Rodeghiero","year":"2017","journal-title":"Ann. Hematol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/rth2.12465","article-title":"The role of platelets in sepsis","volume":"5","author":"Shannon","year":"2021","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"B41","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1177\/0310057X0703500604","article-title":"Thrombocytopenia in septic shock patients\u2014a prospective observational study of incidence, risk factors and correlation with clinical outcome","volume":"35","author":"Sharma","year":"2007","journal-title":"Anaesth. Intensive Care"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1378\/chest.115.5.1363","article-title":"Thrombocytopenia in a surgical ICU","volume":"115","author":"Ste\u00e9phan","year":"1999","journal-title":"Chest"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1097\/00003246-200208000-00015","article-title":"Thrombocytopenia in patients in the medical intensive care unit: Bleeding prevalence, transfusion requirements, and outcome","volume":"30","author":"Strauss","year":"2002","journal-title":"Crit. Care Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/2110-5820-2-42","article-title":"Management of thrombocytopenia in the ICU (pregnancy excluded)","volume":"2","author":"Van der Linden","year":"2012","journal-title":"Ann. Intensive Care"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1097\/00003246-200006000-00031","article-title":"Thrombocytopenia and prognosis in intensive care","volume":"28","author":"Vanderschueren","year":"2000","journal-title":"Crit. Care Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2052-0492-1-9","article-title":"Thrombocytopenia in adult patients with sepsis: Incidence, risk factors, and its association with clinical outcome","volume":"1","author":"Venkata","year":"2013","journal-title":"J. Intensive Care"},{"key":"B47","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction\/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1146\/annurev-physiol-030212-183752","article-title":"Platelets in lung biology","volume":"75","author":"Weyrich","year":"2013","journal-title":"Annu. Rev. Physiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jcrc.2013.11.023","article-title":"Recombinant human thrombopoietin improves platelet counts and reduces platelet transfusion possibility among patients with severe sepsis and thrombocytopenia: A prospective study","volume":"29","author":"Wu","year":"2014","journal-title":"J. Crit. Care"},{"key":"B50","doi-asserted-by":"publisher","first-page":"155227","DOI":"10.1016\/j.cyto.2020.155227","article-title":"Prognosis and rescue therapy for sepsis-related severe thrombocytopenia in critically ill patients","volume":"136","author":"Zhou","year":"2020","journal-title":"Cytokine"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1007719\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T05:41:11Z","timestamp":1665380471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1007719\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":50,"alternative-id":["10.3389\/fphar.2022.1007719"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1007719","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2022,10,10]]},"article-number":"1007719"}}